MedTrace Logo

Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) Translational Study

NCT06145958 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2585

Last updated 2023-11-24

No results posted yet for this study

Summary

The goal of this translational study is to test the use of biomarkers in salvage treatment for prostate cancer after a previous operation to remove the prostate. The main question it aims to answer is:

• Can a biomarker identify a group of patients most likely to benefit from androgen deprivation therapy in conjunction with salvage radiotherapy No new participants will be involved, but tumour samples will be acquired, for patients that gave their permission in the completed RADICALS RT and HD studies.

Conditions

Interventions

DRUG

Luteinising Hormone-Releasing Factor Analogue

Androgen Deprivation Therapy

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • Matthew W Fittall, BMBCh PhD · UCL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2028-08-30
Completion
2028-08-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06145958 on ClinicalTrials.gov